IFN-gamma (3F1E3) Mouse mAb 3159S from Cell Signaling Technology

Product Specs
ItemIFN-gamma (3F1E3) Mouse mAb
CompanyCell Signaling Technology
Price Pricing Info Supplier Page View Company Product Page
Catalog Number3159S
Quantity100 µl
ApplicationsW, IP, E-P
ReactivityH
TargetIFN-gamma
HostMouse
NCBI Gene AliasesIFG, IFI, IMD69
ClonalityMonoclonal
NCBI Full Gene Nameinterferon gamma
Research AreaImmunology and Inflammation
IsotypeIgG1
Clone3F1E3
Molecular Weight17

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) Lnc-PLA2G4A-4 facilitates the progression of hepatocellular carcinoma by inducing versican expression via sponging miR-23b-3pHeliyonAugust 1, 2023Jiahui Xiong, Yongping Lai, Niangmei Cheng, Jizhe Liu, Fei Wang, Xiaoyuan Zheng, Yingchao Wang, Qiuyu Zhuang, Yantin Lin, Jingfeng Liu, et al.at room temperature, the membranes were incubated with primary antibodies against E-cadherin (CST, #3159, 1:1000), N-cadherin (CST, #13116, 1:1000), Vimentin (CST, #5741p, 1:1000), Snail (CST, #3879s, 1:1000),

(2) ProBDNF Upregulation in Murine Hind Limb Ischemia Reperfusion Injury: A Driver of InflammationBiologyJune 24, 2023Aby K, Antony R, Li Y.ABclonal, A4210), MCP-1 (1:1000 Cell Signaling Technology, 2029S), IFN-γ (Cell Signaling Technology, 3159S), TNFα (1:500 Santa Cruz, sc-8301), and TGF-β (1:1000 Biolegend, 141402). Fluorescent dye 2,2,2-trichloroethanol

(3) Neutrophil Extracellular Traps Promote NLRP3 Inflammasome Activation and Glomerular Endothelial Dysfunction in Diabetic Kidney DiseaseNutrientsJuly 20, 2022Gupta A, Singh K, Fatima S, Ambreen S, Zimmermann S, Younis R, Krishnan S, Rana R, Gadi I, Schwab C, et al.(1:1000, Novus NBP1-77080SS), pENOS (1:1000, CST 9572), eNOS (1:1000, CST 9571), Nephrin (1:1000, R&D 3159-NN), PAD4 (1:1000, Novus H00023569-M01), H3Cit (1:1000, abcam ab5103), α-tubulin (1:40,000, CST 2144)

(4) KCNQ1OT1 regulates the retinoblastoma cell proliferation, migration and SIRT1/JNK signaling pathway by targeting miR-124/SP1 axisBioscience reportsJanuary 29, 2021Zhang H, Yang X, Xu Y, Li H.MMP9 (CST, Boston, MA, U.S.A.; cat. no. 13667, 1:1000), E-Cadherin (CST, Boston, MA, U.S.A.; cat. no. 3159), N-Cadherin (CST, Boston, MA, U.S.A.; cat. no. 13116), vimentin (CST, Boston, MA, U.S.A.; cat. no.

(5) Obacunone Protects Against Ulcerative Colitis in Mice by Modulating Gut Microbiota, Attenuating TLR4/NF-κB Signaling Cascades, and Improving Disrupted Epithelial BarriersFrontiers in MicrobiologyMarch 31, 2020Xiaoping Luo, Bei Yue, Zhilun Yu, Yijing Ren, Jing Zhang, Junyu Ren, Zhengtao Wang, Wei Douwere from Cell Signaling Technology (Danvers, MA, United States), as follows: COX-2 (#12282P), IFN-γ (#3159), TNF-α (#3707S), and MyD88 (#42835). All reagents for quantitative polymerase chain reaction (qPCR)

(6) The effects of estradiol on inflammatory and endothelial dysfunction in rats with preeclampsiaInternational Journal of Molecular MedicineJanuary 13, 2020Zhao‑Heng Lin, Jing Jin, Xi‑Yun Shanab2105; 1:1,000; Abcam), IL-6 (cat. no. 12153; 1:1,000; Cell Signaling Technology, Inc.), IFN-γ (cat. no. 3159; 1:1,000; Cell Signaling Technology, Inc.), MCP-1 (cat. no. ab25124; 1:2,000; Abcam), CD49D (cat. no.

(7) Circadian Rhythms and Energy Metabolism Reprogramming in Parkinson's DiseaseCurrent Issues in Molecular BiologyJune 5, 2019Alexandre VallÃ©e, Yves Lecarpentier, Jean-NoÃ«l VallÃ©emetabolism: the good, the bad and the future. Nature Medicine, 19(5), 557-566. https://doi.org/10.1038/nm.3159 Al-Harthi, L. (2012). Wnt/β-catenin and its Diverse Physiological Cell Signaling Pathways in Neurodegenerative

(8)

Downregulation of NSD3 (WHSC1L1) inhibits cell proliferation and migration via ERK1/2 deactivation and decreasing CAPG expression in colorectal cancer cells

OncoTargets and TherapyMay 21, 2019Lanjuan Yi, Lanjie Yi, Qing Liu, Chen Li92056); N-Cadherin (CST, Boston, MA, USA; cat. no. 13116); E-Cadherin (CST, Boston, MA, USA; cat. no. 3159); vimentin (CST, Boston, MA, USA; cat. no. 13116); (CST, Boston, MA, USA; cat. no. 5741); p-ERK1/2 (CST,

(9) The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesisScientific reportsJune 28, 2018Chang CC, Huang YS, Lin YM, Lin CJ, Jeng JC, Liu SM, Ho TL, Chang RT, Changou CA, Ho CC, et al.

(10) EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast CancerScientific ReportsDecember 1, 2017Chao-Qun Wang et al.ErbB signaling network: receptor heterodimerization in development and cancer. The EMBO journal 19, 3159–3167, https://doi.org/10.1093/emboj/19.13.3159 (2000). 24. Schlessinger, J. Cell signaling by receptor

(11) Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathwayOncology ReportsNovember 1, 2016Yuichi Ohnishi, Hiroki Yasui, Kenji Kakudo, Masami NozakiHynes NE: The ErbB signaling network: Receptor heterodimerization in development and cancer. EMBO J 19: 3159-3167, 2000. 2. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 103: 211-225, 2000. 3.

(12) Sphingosine 1-Phosphate Activation of EGFR As a Novel Target for Meningitic Escherichia coli Penetration of the Blood-Brain BarrierPLOS PathogensOctober 6, 2016Xiangru Wang, Ravi Maruvada, Andrew J. Morris, Jun O. Liu, Michael J. Wolfgang, Dong Jae Baek, Robert Bittman, Kwang Sik Kim(2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19: 3159–3167. doi: 10.1093/emboj/19.13.3159 PMID: 10880430 30. Schlessinger J (2000) Cell signaling by receptor

(13) Micro-ribonucleic acid 29b inhibits cell proliferation and invasion and enhances cell apoptosis and chemotherapy effects of cisplatin via targeting of DNMT3b and AKT3 in prostate cancerOncoTargets and TherapyMarch 19, 2015Jin-Rui Yang, Qiong Yan, Xiao-Xin Guo, Xiao-xin Wang, Zhao Wang, Zhuo Yin, Yong-Bao Wei, Yun-Liang Wei, Yun-liang Zhou, Jin-Rui ZhouSMAD3, SOCS5, AKT3, and GAPDH were as follows: ABCAM/ab9870, Cst/5453, Abcam/ab2851, Abcam/ab124294, Cst/3159, Cst/9523, Abcam/ab3695, Cst/8018, and SANTA/SC-365062, respectively. After exposure and development,

(14) The function of human epidermal growth factor receptor-3 and its role in tumors (Review)Oncology ReportsDecember 1, 2013QIN LI, ZHENYAN YUAN, BANGWEI CAOHynes NE: The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19: 3159-3167, 2000. 2. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 103: 211-225, 2000. 3.

(15) Activated Epidermal Growth Factor Receptor is Associated with Cyclooxygenase-2 and Clinical Outcome in Smoking-Related Non-Small Cell Lung CancerMedical OncologyMarch 1, 2010Seok Jin Kim, Zahid N. Rabbani, Fan Dong, Robin T. Vollmer, Ernst-Gilbert Schreiber, Mark W. Dewhirst, Zeljko Vujaskovic, Michael J. KelleyThe ErbB signaling network: receptor heterodimerization in development and cancer. Embo J. 2000; 19:3159–3167. [PubMed: 10880430] 41. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000;

(16) Bioinformatic analysis of xenobiotic reactive metabolite target proteins and their interacting partnersBMC Chemical BiologyDecember 1, 2009Jianwen Fang, Yakov M Koen, Robert P HanzlikGL: Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 2007, 26:3159-3171. Czaja MJ: Cell signaling in oxidative stress-induced liver injury. Seminars in Liver Disease 2007

(17) Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cellsBreast Cancer ResearchAugust 1, 2007Iain R Hutcheson, Janice M Knowlden, Steve E Hiscox, Denise Barrow, Julia M W Gee, John F Robertson, Ian O Ellis, Robert I NicholsonThe ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000, 19:3159-3167. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 2000, 103:211-225. Tzahar E

(18) EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lungOncology ReportsJune 1, 2007Marina Arifin, Keiko Hiyama, Keiji Tanimoto, Wiwien Wiyono, Eiso Hiyama, Masahiko NishiyamaHynes NE: The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19: 3159-3167, 2000. 13. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 103: 211-225, 2000. 14.

(19) Systematic molecular dynamics searching in a lipid bilayer: Application to the glycophorin A and oncogenic ErbB-2 transmembrane domainsJournal of Molecular Graphics and ModellingOctober 1, 2006Andrew J. Beevers, Andreas Kukolsignalling network: receptor heterodimerization in development and cancer. EMBO Journal, 2000. 19(13): p. 3159-3167. Schlessinger, J., Cell Signalling by Receptor Tyrosine Kinases. Cell, 2000. 103: p. 211-225. Klapper,

(20) The Transmembrane Domain of the Oncogenic Mutant ErbB-2 Receptor: A Structure Obtained from Site-specific Infrared Dichroism and Molecular DynamicsJournal of Molecular BiologySeptember 1, 2006Andrew J. Beevers, Andreas KukolThe ErbB signalling network: receptor heterodimerization in development and cancer. EMBO Journal 19, 3159-3167. Schlessinger, J. (2000). Cell Signalling by Receptor Tyrosine Kinases. Cell 103, 211-225. Klapper,

Be the First to Write a Review!

Bench Tips for Optimizing ELISA: It All Comes Out in the Wash
August 22, 2013
This article will provide you with tips on washing your ELISA plates using an automated plate washer, with the goal of avoiding high background and high variation (between plates and between replicate wells). read more

IFN-gamma (3F1E3) Mouse mAb

IFN-gamma (3F1E3) Mouse mAb from Cell Signaling Technology

Description

Cell Signaling Technology

Citations (20)

Reviews

Bench Tips

Bench Tips for Optimizing ELISA: It All Comes Out in the Wash

IFN-gamma (3F1E3) Mouse mAb from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map